[HTML][HTML] TFEB in Alzheimer's disease: From molecular mechanisms to therapeutic implications

Z Gu, H Cao, C Zuo, Y Huang, J Miao, Y Song… - Neurobiology of …, 2022 - Elsevier
Abstract Alzheimer's disease (AD), an age-dependent neurodegenerative disorder, is the
most prevalent neurodegenerative disease worldwide. The primary pathological hallmarks …

[HTML][HTML] Novel insight into functions of transcription factor EB (TFEB) in alzheimer's disease and Parkinson's disease

J Yang, W Zhang, S Zhang, A Iyaswamy, J Sun… - Aging and …, 2023 - ncbi.nlm.nih.gov
A key pathological feature of neurodegenerative diseases (NDs) such as Alzheimer's
disease (AD) and Parkinson's disease (PD) is the accumulation of aggregated and …

[HTML][HTML] Therapeutic potential of vital transcription factors in Alzheimer's and Parkinson's disease with particular emphasis on transcription factor EB mediated …

SN Rai, N Tiwari, P Singh, D Mishra, AK Singh… - Frontiers in …, 2021 - frontiersin.org
Autophagy is an important cellular self-digestion and recycling pathway that helps in
maintaining cellular homeostasis. Dysregulation at various steps of the autophagic and …

TFEB dysregulation as a driver of autophagy dysfunction in neurodegenerative disease: Molecular mechanisms, cellular processes, and emerging therapeutic …

CJ Cortes, AR La Spada - Neurobiology of disease, 2019 - Elsevier
Two decades ago, the recognition of protein misfolding and aggregate accumulation as
defining features of neurodegenerative disease set the stage for a thorough examination of …

The autophagy–lysosomal pathway in neurodegeneration: a TFEB perspective

H Martini-Stoica, Y Xu, A Ballabio, H Zheng - Trends in neurosciences, 2016 - cell.com
The autophagy–lysosomal pathway (ALP) is involved in the degradation of long-lived
proteins. Deficits in the ALP result in protein aggregation, the generation of toxic protein …

The regulatory mechanism and therapeutic potential of transcription factor EB in neurodegenerative diseases

F Jiao, B Zhou, L Meng - CNS Neuroscience & Therapeutics, 2023 - Wiley Online Library
The autophagy‐lysosomal pathway (ALP) is involved in the degradation of protein
aggregates and damaged organelles. Transcription factor EB (TFEB), a major regulator of …

[HTML][HTML] Transcription factor EB is selectively reduced in the nuclear fractions of Alzheimer's and amyotrophic lateral sclerosis brains

H Wang, R Wang, S Xu, MK Lakshmana - Neuroscience Journal, 2016 - hindawi.com
Multiple studies suggest that autophagy is strongly dysregulated in Alzheimer's disease (AD)
and amyotrophic lateral sclerosis (ALS), as evidenced by accumulation of numerous …

TFEB participates in the Aβ-induced pathogenesis of Alzheimer's disease by regulating the autophagy-lysosome pathway

Y Zhang, J Zhao - DNA and cell biology, 2015 - liebertpub.com
To investigate whether transcriptional factor EB (TFEB) participates in amyloid-β1–42 (Aβ1–
42)-induced pathogenesis of Alzheimer's disease (AD) and its underlying mechanisms …

Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB

VA Polito, H Li, H Martini‐Stoica, B Wang… - EMBO molecular …, 2014 - embopress.org
Accumulating evidence implicates impairment of the autophagy‐lysosome pathway in
Alzheimer's disease (AD). Recently discovered, transcription factor EB (TFEB) is a molecule …

Methods to monitor and manipulate TFEB activity during autophagy

DL Medina, C Settembre, A Ballabio - Methods in Enzymology, 2017 - Elsevier
Macroautophagy is a catabolic process deputed to the turnover of intracellular components.
Recent studies have revealed that transcriptional regulation is a major mechanism …